Sanofi aims to boost competition in the atopic dermatitis market, following Dupixent's success, with new treatments like ...

Sanofi and Regeneron's Dupixent is on track to become the first targeted drug in the EU to be approved for prurigo nodularis (PN), a rare and highly debilitating skin disease. The EMA's human ...

Sanofi and Regeneron have celebrated a pair of positive clinical trials in inflammatory skin disorders with blockbuster immunology therapy Dupixent that could both lead to new indications for the ...

You can inject Dupixent as a subcutaneous injection (injection under your skin). Injection site reactions, such as pain, are common side effects of Dupixent. Learn more about those side effects ...

Regeneron shares have been in a bearish trend since August, losing over one third of their value. Read why I am initiating ...

Dupixent® is now used to treat over a million patients globally, with continued growth and expansion in multiple indications for diseases in ...

Eli Lilly (NYSE:LLY) said a Phase 3b study of its drug Ebglyss showed it was able to improve skin and itch in patients ...

The cost of Dupixent can vary based on several factors, including your insurance coverage. Coupons and drug savings programs can also lower the price you’ll pay for Dupixent. Specifically ...

Dupixent is FDA approved for adults and children ... This is another option for patients who cannot adequately control their skin conditions with topicals. For some people, keeping up with eczema ...